These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26352884)

  • 21. Immune responses to varicella zoster virus infections in healthy children.
    Rotbart HA; Levin MJ; Hayward AR
    J Infect Dis; 1993 Jan; 167(1):195-9. PubMed ID: 8380291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varicella-zoster virus seroprevalence in healthcare workers in Kuala Lumpur, Malaysia.
    Sam IC; Tariman H; Chan YF; Bador MK; Yusof MY; Hassan H
    Med J Malaysia; 2008 Dec; 63(5):429-30. PubMed ID: 19803311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pox in the docks: varicella outbreak in an Australian prison system.
    Levy MH; Quilty S; Young LC; Hunt W; Matthews R; Robertson PW
    Public Health; 2003 Nov; 117(6):446-51. PubMed ID: 14522161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunoassay for antibodies in varicella-zoster virus serology.
    Trlifajova J; Pokorný J; Nĕmecek V; Ryba M
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):332-9. PubMed ID: 231068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella Zoster antibodies among health care workers in a university hospital, Teheran, Iran.
    Talebi-Taher M; Noori M; Shamshiri AR; Barati M
    Int J Occup Med Environ Health; 2010; 23(1):27-32. PubMed ID: 20442060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High levels of antibody to varicella-zoster virus in systemic lupus erythematosus.
    Nagasawa K; Yamauchi Y; Tada Y; Tsukamoto H; Mayumi T; Niho Y
    J Infect Dis; 1992 Sep; 166(3):692-4. PubMed ID: 1323629
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
    Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
    Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Most ten-year-old children with negative or unknown histories of chickenpox are immune.
    Boulianne N; Duval B; De Serres G; Deceuninck G; Massé R; Couillard M
    Pediatr Infect Dis J; 2001 Nov; 20(11):1087-8. PubMed ID: 11734718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The utility of serologic testing for varicella in an adolescent population.
    Heininger U
    Vaccine; 2002 Feb; 20(11-12):1480. PubMed ID: 11858852
    [No Abstract]   [Full Text] [Related]  

  • 31. Seroepidemiology of varicella-zoster virus in Bangladesh.
    Saha SK; Darmstadt GL; Hanif M; Khan R
    Ann Trop Paediatr; 2002 Dec; 22(4):341-5. PubMed ID: 12530284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varicella zoster virus immunisation.
    Holzel H; Jumaa P
    Lancet; 1999 Oct; 354(9185):1207. PubMed ID: 10513734
    [No Abstract]   [Full Text] [Related]  

  • 33. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
    Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
    Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PROTECTIVE LEVELS OF VARICELLA-ZOSTER ANTIBODY DID NOT EFFECTIVELY PREVENT CHICKENPOX IN AN X-LINKED AGAMMAGLOBULINEMIA PATIENT.
    Nobre FA; Gonzalez IG; de Moraes-Pinto MI; Costa-Carvalho BT
    Rev Inst Med Trop Sao Paulo; 2015; 57(5):455-7. PubMed ID: 26603238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella seroprevalence in Turkish population in Cyprus.
    Kurugol Z; Koturoglu G; Aksit S; Ozacar T
    Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunity to varicella-zoster virus in a normal adult population.
    Ndumbe PM; Macqueen S; Holzel H; Levinsky RJ
    J Med Microbiol; 1985 Aug; 20(1):105-11. PubMed ID: 2991523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A seroepidemiological study of Varicella-Zoster virus in Taipei City.
    Lin YJ; Huang LM; Lee CY; Chih TW; Lee PL; Chang LY; Hsu CM
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(1):11-5. PubMed ID: 8936004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indirect haemagglutination reaction with varicella-zoster virus antigen.
    Trlifajová J; Pokorný J; Ryba M; Strízová V
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):26-36. PubMed ID: 4350836
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunologic evidence of reinfection with varicella-zoster virus.
    Talbot GH; Skros M; Fisher M; Friedman H
    J Infect Dis; 1984 Jun; 149(6):1035-6. PubMed ID: 6330237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.